SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences advances on plan to set up a new facility in Gujarat

10 Aug 2015 Evaluate

Camlin Fine Sciences is currently trading at Rs. 105.80, up by 2.70 points or 2.62% from its previous closing of Rs. 103.10 on the BSE.

The scrip opened at Rs. 103.80 and has touched a high and low of Rs. 106.80 and Rs. 103.50 respectively. So far 1,08,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 128.80 on 29-Jun-2015 and a 52 week low of Rs. 47.45 on 08-Aug-2014.

Last one week high and low of the scrip stood at Rs. 118.80 and Rs. 102.60 respectively. The current market cap of the company is Rs. 1,011.00 crore.

The promoters holding in the company stood at 52.20% while Institutions and Non-Institutions held 1.08% and 46.72% respectively.

In a bid to produce hydroquinone and vanillin, food antioxidant and ingredient manufacturer Camlin Fine Sciences has decided to set up a new facility in Gujarat. In this regard, the company has acquired a land at Dahej SEZ in Gujarat for setting up a plant with an investment of Rs 180 crore. The facility will have capacity to manufacture 9,000 tonnes per annum of hydroquinone and 6,000 tonnes per annum of vanillin.

The company has already appointed the project management consultant of international repute and the project is expected to be commissioned sometime during the later of part of financial year 2017-18 and the full-scale manufacturing operations are expected to start from FY 2018-19.

Camlin Fine is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).


Camlin Fine Sciences Share Price

126.97 4.00 (3.25%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×